X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TORRENT PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER TORRENT PHARMA PFIZER/
TORRENT PHARMA
 
P/E (TTM) x 33.4 60.3 55.4% View Chart
P/BV x 5.3 5.7 92.8% View Chart
Dividend Yield % 0.6 0.9 71.7%  

Financials

 PFIZER   TORRENT PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-18
TORRENT PHARMA
Mar-18
PFIZER/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs2,3651,550 152.6%   
Low Rs1,6251,144 142.1%   
Sales per share (Unadj.) Rs430.3354.7 121.3%  
Earnings per share (Unadj.) Rs78.740.1 196.4%  
Cash flow per share (Unadj.) Rs93.264.2 145.1%  
Dividends per share (Unadj.) Rs20.0014.00 142.9%  
Dividend yield (eoy) %1.01.0 96.4%  
Book value per share (Unadj.) Rs586.5273.1 214.7%  
Shares outstanding (eoy) m45.75169.22 27.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.63.8 122.1%   
Avg P/E ratio x25.333.6 75.4%  
P/CF ratio (eoy) x21.421.0 102.1%  
Price / Book Value ratio x3.44.9 69.0%  
Dividend payout %25.434.9 72.7%   
Avg Mkt Cap Rs m91,271227,897 40.0%   
No. of employees `0002.614.7 17.9%   
Total wages/salary Rs m3,14311,353 27.7%   
Avg. sales/employee Rs Th7,484.84,083.0 183.3%   
Avg. wages/employee Rs Th1,195.0772.3 154.7%   
Avg. net profit/employee Rs Th1,369.1461.3 296.8%   
INCOME DATA
Net Sales Rs m19,68560,021 32.8%  
Other income Rs m1,1432,988 38.2%   
Total revenues Rs m20,82863,009 33.1%   
Gross profit Rs m5,00313,493 37.1%  
Depreciation Rs m6634,086 16.2%   
Interest Rs m43,085 0.1%   
Profit before tax Rs m5,4799,310 58.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8782,529 74.3%   
Profit after tax Rs m3,6016,781 53.1%  
Gross profit margin %25.422.5 113.1%  
Effective tax rate %34.327.2 126.2%   
Net profit margin %18.311.3 161.9%  
BALANCE SHEET DATA
Current assets Rs m24,16752,623 45.9%   
Current liabilities Rs m9,54452,022 18.3%   
Net working cap to sales %74.31.0 7,412.4%  
Current ratio x2.51.0 250.3%  
Inventory Days Days55120 46.1%  
Debtors Days Days2976 37.7%  
Net fixed assets Rs m9,51485,016 11.2%   
Share capital Rs m458846 54.1%   
"Free" reserves Rs m26,37545,376 58.1%   
Net worth Rs m26,83246,222 58.1%   
Long term debt Rs m2541,115 0.1%   
Total assets Rs m36,900142,432 25.9%  
Interest coverage x1,305.54.0 32,492.0%   
Debt to equity ratio x00.9 0.1%  
Sales to assets ratio x0.50.4 126.6%   
Return on assets %9.86.9 141.0%  
Return on equity %13.414.7 91.5%  
Return on capital %20.414.2 143.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2214,580 0.2%   
Fx outflow Rs m1,4893,600 41.4%   
Net fx Rs m-1,46610,980 -13.4%   
CASH FLOW
From Operations Rs m3,3188,942 37.1%  
From Investments Rs m-2,383-47,070 5.1%  
From Financial Activity Rs m-1,10434,174 -3.2%  
Net Cashflow Rs m-169-3,655 4.6%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 7.0 106.8%  
FIIs % 4.9 12.6 38.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 8.8 269.3%  
Shareholders   85,207 26,511 321.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. REDDYS LAB  STERLING BIOTECH  NATCO PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Dip After Record Rally; Sensex Ends 298 Points Lower(Closing)

It was a volatile day for Indian share markets today. The BSE Sensex and NSE Nifty opened at record high and went on to touch 40,000 and 12,000.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 23, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS